At OMRF, Shah will serve as a technology development specialist.
Is a Covid-19 vaccine before the end of the year still a reality?
Typically, a promising new experimental drug arrives on the scene with a flourish. But sometimes, it’s a long and winding road.
This collaboration is part of GSK’s “Discovery Partnerships with Academia” (DPAc) efforts.